Murewa is a doctoral student in the Department of Behavioral and Community Health. She holds a Master of Health Science Degree from the Johns Hopkins Bloomberg School of Public Health with a concentration in behavioral science and health education. Her professional and research interests include health literacy, consumer study research, medication and device use education. Additionally, Murewa is a Social Scientist at the Food and Drug Administration (FDA) where she serves as a Senior Regulatory Management Officer in the Division of Therapeutic Performance in the Office of Research and Standards in the Office Generics Drugs (OGD). She is also an Officer in the U.S. Public Health Service Corp (USPHS).
Kish-Doto, J., Scales, M., Eguino-Medina ,P., Fitzgerald, T., Tzeng, J., McCormack, L., Donoghue, A., Oguntimein, O., & West, S. Preference for Patient Medication Information: What Do Patient Want?. Journal of Health Communication (In press).
Gamaldo, C. E., Benbrook, A. R., Allen, R. P, Oguntimein, O., & Earley, C. J. A further evaluation of the cognitive defects associated with restless legs syndrome (RLS). Sleep Medicine. 2009; 9(5): 500-5.
Gamaldo, C. E., Benbrook, A. R., Allen, R. P, Oguntimein, O., & Earley, C. J. Evaluating daytime alertness in individuals with restless legs syndrome (RLS) compared to sleep restricted controls. Sleep Medicine. 2009; 10(1): 134-8.